血液動力學監測系統市場規模、佔有率、成長分析：按產品、類型、最終用戶、地區 - 產業預測，2024-2031

預計2022年全球血流動力學監測系統市場規模將達11億美元，從2023年的11.6億美元增加至2031年的19.2億美元，預計複合年成長率為6.4%。

由於幾個關鍵因素（主要是高科技創新），血液動力學監測系統市場正在強勁成長。低血壓預測指數 (HPI) 軟體的整合等進步極大地提高了這些醫療設備的準確性和功能。同時，針對血流動力學監測系統的研究的增加正在刺激其在臨床實踐中的發展和採用。全球心血管疾病和糖尿病發生率的增加增加了對先進監測解決方案的需求。此外，老年人口的增加和外科手術比例的增加正在推動市場擴張。此外，電子機械系統 (MEMS) 的採用凸顯了我們對最尖端科技的承諾，以提供更好的患者照護。旨在加強醫療基礎設施的政府措施也是支持市場成長的關鍵因素。隨著血流動力學監測系統不斷進步並在重症加護領域獲得關注，在技術創新、醫療保健需求和策略意識舉措的推動下，市場成長軌跡可能會持續下去。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價值鏈分析
• 市場生態系統
• 監管環境
• 創新矩陣
• 主要投資分析
• 關鍵成功因素
• 市場魅力指數
• 競爭程度

血流動力學監測系統市場：依產品

• 市場概況
• 監視器
• 消耗品
• 其他

血流動力學監測系統市場：按類型

• 市場概況
• 侵入性的
• 非侵入性
• 其他

血流動力學監測系統市場：依最終用戶分類

• 市場概況
• 醫院
• 診所
• 門診治療中心
• 居家醫療
• 其他

按地區分類的血流動力學監測系統市場規模

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Edwards Lifesciences Corporation（United States）
• ICU Medical, Inc.（United States）
• Baxter International Inc.（United States）
• LiDCO Group Plc（United Kingdom）
• Cheetah Medical（United States）
• Deltex Medical Group plc（United Kingdom）
• GE Healthcare（United States）
• Philips Healthcare（Netherlands）
• Nihon Kohden Corporation（Japan）
• Siemens Healthineers AG（Germany）
• CardioDynamics International Corporation（United States）
• Osypka Medical GmbH（Germany）
• Schwarzer Cardiotek GmbH（Germany）
• Uscom Limited（Australia）
• Getinge AB（Sweden）
• Nonin Medical, Inc.（United States）
• Tensys Medical, Inc.（United States）
• CareTaker Medical, LLC（United States）
• CNSystems Medizintechnik AG（Austria）
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（China）

Global Hemodynamic Monitoring Systems Market size was valued at USD 1.10 billion in 2022 and is poised to grow from USD 1.16 billion in 2023 to USD 1.92 billion by 2031, growing at a CAGR of 6.4% in the forecast period (2024-2031).

The hemodynamic monitoring systems market is experiencing robust growth driven by several key factors, primarily advanced technological innovations. These advancements, such as the integration of hypotension prediction index (HPI) software, have significantly improved the accuracy and capabilities of these medical devices. Concurrently, increased research dedicated to hemodynamic monitoring systems is fueling their evolution and adoption across clinical settings. Demand is further bolstered by rising global incidences of cardiovascular diseases and diabetes, prompting a surge in the need for sophisticated monitoring solutions. Additionally, a growing elderly population and escalating rates of surgical procedures are pivotal in propelling market expansion. Industry efforts to raise awareness about the benefits of these systems among enterprises are expanding their market reach, while the adoption of microelectromechanical systems (MEMS) underscores a commitment to cutting-edge technologies for better patient care. Government initiatives aimed at strengthening healthcare infrastructure are also pivotal in supporting market growth. As hemodynamic monitoring systems continue to advance and gain prominence in critical care, their trajectory of market growth is poised to persist, driven by technological innovation, healthcare demands, and strategic awareness initiatives.

Top-down and bottom-up approaches were used to estimate and validate the size of the Hemodynamic Monitoring Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Hemodynamic Monitoring Systems Market Segmental Analysis

The global hemodynamic monitoring systems market is segmented on the basis of product, type, end user, and region. Based on product, the market is segmented into monitors and disposables. Based on type, the market is segmented into Invasive, Non-invasive and Others. Based on end user, the market is segmented into Hospitals, Clinics, Ambulatory care centers, Home Care Settings and Others. Based on region, the market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East & Africa.

Drivers of the Hemodynamic Monitoring Systems Market

Advancements in hemodynamic monitoring systems have continually evolved, ushering in significant technological progress and the development of increasingly sophisticated, precise, and non-invasive monitoring devices. This evolution has profoundly influenced patient outcomes and healthcare efficiency. The introduction of non-invasive hemodynamic monitoring devices, employing sensors on the patient's skin for measuring blood flow and pressure, represents a revolutionary shift in monitoring practices.

Restraints in the Hemodynamic Monitoring Systems Market

Noninvasive hemodynamic monitoring systems represent a significant advancement in medical diagnostics, offering painless procedures and reducing the risk of blood-borne infections in patients. Their simplicity and accessibility make them suitable for use by nurses without specialized medical training, facilitating simultaneous monitoring of multiple patients' hemodynamic states. This streamlined approach not only simplifies monitoring but also lowers staffing and treatment costs. These inherent benefits underscore the pivotal role of noninvasive hemodynamic monitoring systems in modern healthcare, driving their widespread adoption and promising market growth in the coming years.

Market Trends of the Hemodynamic Monitoring Systems Market

The hemodynamic monitoring systems market is experiencing robust growth driven by multiple factors. These include the rising population of critically ill elderly individuals, the high incidence of heart diseases and diabetes, increasing demand for non-invasive and home-based monitoring solutions, and a growing number of hypertensive patients. The aging demographic, prone to various health challenges and critical illnesses, underscores the escalating need for advanced monitoring technologies. Globally prevalent heart diseases and diabetes further amplify the demand for such monitoring systems.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Market Attractive Index
• Degree of Competition

Global Hemodynamic Monitoring Systems Market by Product

• Market Overview
• Monitors
• Disposables
• Others

Global Hemodynamic Monitoring Systems Market by Type

• Market Overview
• Invasive
• Non-invasive
• Others

Global Hemodynamic Monitoring Systems Market by End User

• Market Overview
• Hospitals
• Clinics
• Ambulatory care centres
• Home care settings
• Others

Global Hemodynamic Monitoring Systems Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Edwards Lifesciences Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LiDCO Group Plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cheetah Medical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Deltex Medical Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioDynamics International Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Osypka Medical GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schwarzer Cardiotek GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Uscom Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nonin Medical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tensys Medical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareTaker Medical, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CNSystems Medizintechnik AG (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments